Colin J Mahoney
Overview
Explore the profile of Colin J Mahoney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazumder S, Carroll A, Timmins H, Kiernan M, Mahoney C
Front Neurol
. 2025 Mar;
16:1514983.
PMID: 40046669
Background And Aims: During the COVID-19 pandemic, vulnerable populations faced worsening mental and physical well-being due to limited access to support systems and diverted health resources during lockdowns. Individuals with...
2.
Almgren H, Mahoney C, Huynh W, DSouza A, Berte S, Lv J, et al.
J Neurol
. 2025 Feb;
272(3):215.
PMID: 39969638
Background: Diffusion MRI is sensitive to white matter changes in amyotrophic lateral sclerosis (ALS). The current study aimed to establish disease profiles across core motor pathways, and their relevance to...
3.
Tu S, Li T, Carroll A, Mahoney C, Huynh W, Park S, et al.
Sci Rep
. 2024 Aug;
14(1):18331.
PMID: 39112530
Spinal and bulbar muscular atrophy (SBMA), or Kennedy's disease (KD), is a rare hereditary neuromuscular disorder demonstrating commonalities with amyotrophic lateral sclerosis (ALS). The current study aimed to define functional...
4.
Dharmadasa T, Pavey N, Tu S, Menon P, Huynh W, Mahoney C, et al.
Clin Neurophysiol
. 2024 May;
163:68-89.
PMID: 38705104
Identifying upper motor neuron (UMN) dysfunction is fundamental to the diagnosis and understanding of disease pathogenesis in motor neuron disease (MND). The clinical assessment of UMN dysfunction may be difficult,...
5.
Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems
Brodtmann A, Darby D, Oboudiyat C, Mahoney C, Le Heron C, Panegyres P, et al.
Med J Aust
. 2023 Mar;
218(6):247-249.
PMID: 36934371
No abstract available.
6.
Mahoney C, Sleeman R, Errington W
BMJ
. 2022 Nov;
379:e073857.
PMID: 36418041
No abstract available.
7.
Mazumder S, Kiernan M, Halliday G, Timmins H, Mahoney C
Neuropathol Appl Neurobiol
. 2022 Aug;
48(7):e12845.
PMID: 35921237
Over the past decade, considerable efforts have been made to accelerate pathophysiological understanding of fatal neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) with brain banks at the forefront. In...
8.
Devenney E, McErlean K, Tse N, Caga J, Dharmadasa T, Huynh W, et al.
Front Neurol
. 2021 Dec;
12:743688.
PMID: 34899567
This study aimed to establish (1) the pattern and severity of neuropsychiatric symptoms and other non-motor symptoms of sleep and mood, across ALS phenotypes in comparison to bvFTD and (2)...
9.
Tu S, Huang M, Caga J, Mahoney C, Kiernan M
Front Neurol
. 2021 Jul;
12:704059.
PMID: 34305804
Pseudobulbar affect is a disorder of emotional expression commonly observed in amyotrophic lateral sclerosis (ALS), presenting as episodes of involuntary laughter, or crying. The objective of the current study was...
10.
Mahoney C, Ahmed R, Huynh W, Tu S, Rohrer J, Bedlack R, et al.
CNS Drugs
. 2021 May;
35(5):483-505.
PMID: 33993457
Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease typically presenting with bulbar or limb weakness. There is increasing evidence that amyotrophic lateral sclerosis is a multisystem disease with...